Anti-p38γ MAPK Antibody, clone 1N13 ZooMAb® Rabbit Monoclonal

Description

• General description: We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry.This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
• Specificity: Clone 1N13 is a ZooMAb® Rabbit recombinant monoclonal antibody that specifically detects p38g MAP kinase. It targets an epitope within 23 amino acids from the C-terminal region.
• Immunogen: KLH-conjugated linear peptide corresponding to 23 amino acids from the C-terminal region of human p38g MAP kinase.
• Application: Quality Control TestingEvaluated by Western Blotting in HeLa cell lysate.Western Blotting Analysis: A 1:1,000 dilution of this antibody detected p38 MAPK in HeLa cell lysate.Tested applicationsWestern Blotting Analysis: A 1:1,000 dilution from a representative lot detected p38g MAPK in C6 and HepG2 cell lysates.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected p38g MAPK in human skeletal muscle tissue sections.Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected p38g MAPK in A431, HeLa, HepG2, and NIH3T3 cells.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
• Target description: Mitogen-activated protein kinase 12 (UniProt: P53778; also known as EC:2.7.11.24, MAP kinase 12, MAPK 12, Extracellular signal-regulated kinase 6, ERK-6, Mitogen-activated protein kinase p38 gamma, MAP kinase p38 gamma, Stress-activated protein kinase 3) is encoded by the MAPK12 (also known as ERK6, SAPK3) gene (Gene ID: 6300) in human. p38g is a serine/threonine kinase that is an essential component of the MAP kinase signaling pathway. It plays an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines and physical stress leading to direct activation of ELK1 and ATF2. It is highly expressed in skeletal muscle and heart during muscle differentiation and its knockdown is reported to impair cardiomyocyte formation. It also plays a role in blocking premature differentiation of myoblast and skeletal muscle stem cells. p38g is also required for the upregulation of PGC-1a in mitochondrial biogenesis in response to endurance exercise. It is activated by dual phosphorylation of Thr-183 and Tyr-185 by MKK3 and MKK6. It is shown to be overexpressed in highly metastatic breast cancer cell lines and its expression is preferentially associated with basal-like and metastatic phenotypes of breast tumor samples. Its expression is reported to be down-regulated by p38g and its interaction with the single PDZ domain of protein tyrosine phosphatase (PTPH1) leads to its dephosphorylation and inactivation. This ZooMAb® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Escos, A., et al. (2016). Front. Cell Dev. Biol., 4; 31; Gillespie, MA., et al. (2009). J. Cell Biol. 187(7); 991-1005).
• Physical form: Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.
• Reconstitution: 300 μg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
• Storage and Stability: Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
• Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
• Disclaimer: Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.